Save your place

Sign in to WhoBought

Please try again later.

Joel Greenblatt's Sarepta Therapeutics, Inc. (SRPT) position

Yes: as of Q1 2026, Joel Greenblatt holds 48K shares of SRPT worth an amount we cannot price (0.0% of the disclosed portfolio). Last quarter the position was reduced by 78.6%. First disclosed Q1 2022.
View full portfolio →
Current value
an amount we cannot price
Shares held
48K
% of portfolio
0.0%
Quarter-end price
No quarter-end price available

Average buy price is hidden here because at least one covered purchase quarter has no usable local mean price.

SRPT price vs Greenblatt's position

Dates
$14$16$18$20← Earlier —3 purchases, 4 sells
Average closing price · filing quarter
Price range · filing quarter

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q1 2026 Reduced −174K −78.6% 48K May 15, 2026
Q4 2025 New +222K 222K Feb 17, 2026
Q1 2023 Reduced −1K −33.0% 3K May 15, 2023
Q4 2022 Reduced −10K −69.3% 4K Feb 14, 2023
Q3 2022 Added +9K +164.2% 14K Nov 14, 2022
Q2 2022 Reduced −7K −57.8% 5K Aug 15, 2022
Q1 2022 New +12K 12K May 16, 2022
Data through Q1 2026 · filed May 15, 2026
7 grouped rows from 7 quarters

More Greenblatt positions

Common questions

Does Joel Greenblatt own SRPT?

Yes. As of Q1 2026, Joel Greenblatt disclosed 48K shares of SRPT, worth an amount we cannot price. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Joel Greenblatt buy SRPT?

Joel Greenblatt first disclosed a SRPT position in Q1 2022; every quarterly buy and sell since is in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Joel Greenblatt sell SRPT?

The quarter-by-quarter table above shows each sale and reduction Joel Greenblatt disclosed in SRPT. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of SRPT does Joel Greenblatt own?

Joel Greenblatt disclosed 48K shares of SRPT as of Q1 2026. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Joel Greenblatt pay for SRPT?

Joel Greenblatt began building the SRPT position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.